96
Participants
Start Date
July 6, 2020
Primary Completion Date
June 8, 2021
Study Completion Date
June 8, 2021
Degarelix
Degarelix is an FDA-approved drug for prostate cancer
Saline
09% Saline
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, Brooklyn
Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
Miami VA Healthcare System, Miami, FL, Miami
Memphis VA Medical Center, Memphis, TN, Memphis
St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Phoenix VA Health Care System, Phoenix, AZ, Phoenix
VA Greater Los Angeles Healthcare System, West Los Angeles, CA, Los Angeles
VA Long Beach Healthcare System, Long Beach, CA, Long Beach
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock
Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
VA Office of Research and Development
FED